EVIIVE AG
PrivateLast Round
Accelerator
Dec 27, 2024
Total Funding Raised
$462,800
Momentum
Top 50%
of companies Caplight tracks
Company Overview
EVIIVE AG is a biotech company developing a next-generation liquid biopsy platform using extracellular vesicle (EV) analysis and machine learning to guide personalized treatment decisions in immuno-oncology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Clinical Trials, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EVIIVE AG Comparables
Compare EVIIVE AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mursla Bio | 77% | |
| Exosomics S.p.A. | 74% | |
| Mercy BioAnalytics | 70% | |
EVIIVE AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Dec 27, 2024 | ||||
| Grant | Oct 1, 2024 | ||||
| Grant | Nov 1, 2023 | ||||
| Grant | Sep 1, 2023 | ||||
| Grant | Dec 16, 2022 |
EVIIVE AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gebert Rüf Stiftung | Grant |
| Werner Siemens-Stiftung | Grant |
| Swiss National Science Foundation | Grant |
| Innosuisse | Grant |
| University of Zurich | Grant |
| Venture Kick | Accelerator, Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Monthly visitors increased 429% MoM.
- Nov 7, 2025
Monthly visitors increased 147% MoM.
EVIIVE AG Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about EVIIVE AG's valuation, stock price, and market status.